New breast cancer treatment timing tested for safety and effectiveness

NCT ID NCT01928589

Ongoing Disease control Sponsor: Richard Zellars Source: ClinicalTrials.gov ↗

Summary

This study is testing whether giving a shorter course of radiation to just part of the breast at the same time as chemotherapy is as safe and works as well as giving the radiation and chemotherapy at separate times. It involves women with early-stage breast cancer who have had surgery and need both treatments. The goal is to see if the new, combined timing approach controls the cancer just as well while keeping side effects manageable.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

IU Health Arnett

Lafayette, Indiana, 47905, United States
Indiana University Health Hospital

Indianapolis, Indiana, 46202, United States
Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center

Indianapolis, Indiana, 46202, United States
John Hopkins University

Baltimore, Maryland, 21218, United States
Parkview Regional Medical Center

Fort Wayne, Indiana, 46845, United States
Reading Hospital

West Reading, Pennsylvania, 19611, United States
Sibley Memorial Hospital

Washington D.C., District of Columbia, 20016, United States
Suburban Hospital

Bethesda, Maryland, 20814, United States
University of Texas-San Antonio

San Antonio, Texas, 78229, United States
York Cancer Center

York, Pennsylvania, 17403, United States

Conditions

Explore the condition pages connected to this study.

ADENOCARCINOMA OF THE BREAST BREAST CANCER